Update: S×F vari­­ance test [Regulatives / Guidelines]

posted by AngusMcLean – USA, 2014-12-09 18:47 (4218 d 06:58 ago) – Posting: # 14038
Views: 16,716

From above message the output 4 period replicate FDA template is repeated as follows:

Dependent Parameter Estimate
ln Cmax lambda(1,1)_11 is 0.82840679
ln Cmax lambda(1,2)_11 is 0.85299475
ln Cmax lambda(2,2)_11 is 5.63E-07
ln Cmax Var(Period*Formulation*Subject)_21 is 0.11739425
ln Cmax Var(Period*Formulation*Subject)_22 is 0.20211805

From Ana’s message the value for subj. formulation interaction(sig_D^2) is as follows:

(0.82840679)+(5.63E-07)-2*(0.85299475)= -0.87758

Here are my results from the same data set in Phoenix: my input structure is different
Data lambda(1,1)_11 0.85299471
Data lambda(1,2)_11 0.82840678
Data lambda(2,2)_11 8.34E-07
Data Var(Period*Formulation*Subject)_21 0.20211811
Data Var(Period*Formulation*Subject)_22 0.11739421

I used BABA for the input for the first subject. If you look at the Parameter Key and Group Levels on the Parameter Key Output Workbook in Phoenix I have first output parameter as reference not test. That is why there is transposition in the parameter values.
Thread locked

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
299 visitors (0 registered, 299 guests [including 70 identified bots]).
Forum time: 02:45 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5